Antiparkinsonism anticholinergics increase dementia risk in patients with Parkinson’s disease.

Antiparkinsonism anticholinergics increase dementia risk in patients with Parkinson’s disease.
Antiparkinsonism anticholinergics increase dementia risk in patients with Parkinson's disease. Parkinsonism Relat Disord. 2019 Jun 25;: Authors: Hong CT, Chan L, Wu D, Chen WT, Chien LN Abstract INTRODUCTION: Treatment with antiparkinsonism anticholinergics (AAs) has been well-established for patients with Parkinson's disease (PD), especially for tremor. However, concerns regarding the association between anticholinergics and dementia risk are increasing. This retrospective ... read more
Source: PubMedPublished on 2019-07-01